+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Custom Antibody Market by Service (Antibody Development, Production, Labelling), Type (Monoclonal, Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area (Oncology, Immunology), End User (Pharmaceutical Companies, CROs) - Forecast to 2026

  • ID: 5321665
  • Report
  • May 2021
  • Region: Global
  • 189 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Abbiotec, Inc.
  • BioLegend, Inc.
  • Capralogics, Inc.
  • GenScript
  • Merck KGaA
  • ProteoGenix

The global custom antibody market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period.


The increasing demand for protein therapeutics is expected to drive the custom antibody market in the coming years. On the other hand, the need for significant capital investments and long duration of antibody development.



By service, the monoclonal antibody segment accounted for the largest share of the custom antibody market

Based on service, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. Antibody development services accounted for the largest market share in 2020. The large share of this segment can be attributed to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.

Asia Pacific: The fastest-growing region in the custom antibody market

The Asia Pacific market is estimated to witness the highest growth during the forecast period, primarily due to the increasing investments by governments and industries, growing biotechnology research, and rising awareness on personalized therapeutics.

North America: The largest share of the custom antibody market

In 2020, North America accounted for the largest share in the global custom antibody market. The dominance of the North American region can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, increasing focus on developing antibody-based therapeutics, and the presence of a large number of global players in this region.

Breakdown of Primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The primaries are broken down as follows:


  • By Respondent: Supply Side - 50%, Demand Side - 50%
  • By Designation: Executives - 30%, CXOs, Directors- 30%, Managers - 40%
  • By Region: North America - 40%, Europe - 20%, APAC - 20%, RoW - 20%

The custom antibody market is dominated by a few globally established players such as Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Abcam plc (UK), Cell Signaling Technology, Inc. (US), Agilent Technologies, Inc. (US), GenScript (US), BioLegend, Inc. (US), Rockland Immunochemicals, Inc. (US), ProMab Biotechnologies (US), Innovagen AB (Sweden), and ProteoGenix (US).

Research Coverage

The report segments the custom antibody market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), service (antibody development, antibody production & purification, and antibody fragmentation & labeling), type (monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies), source (mice, rabbits, and other sources.), research area (oncology, infectious diseases, neurobiology, stem cells, immunology, cardiovascular disease, and other research areas), end users (pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the custom antibody market.

Reasons to Buy the Report


  • The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments.
  • This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.
  • The report also helps stakeholders understand the pulse of the custom antibody market and provides them information on key market drivers, challenges, and opportunities.
Frequently Asked Questions about the Global Custom Antibody Market

What is the estimated value of the Global Custom Antibody Market?

The Global Custom Antibody Market was estimated to be valued at $393.0 Million in 2021.

What is the growth rate of the Global Custom Antibody Market?

The growth rate of the Global Custom Antibody Market is 10.6%, with an estimated value of $652.0 Million by 2026.

What is the forecasted size of the Global Custom Antibody Market?

The Global Custom Antibody Market is estimated to be worth $652.0 Million by 2026.

Who are the key companies in the Global Custom Antibody Market?

Key companies in the Global Custom Antibody Market include Abbiotec, Inc., Abcam plc, Agilent Technologies, Inc., Bio, Rad Laboratories, Inc., Bio, Techne, BioLegend, Inc. and Capralogics, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbiotec, Inc.
  • BioLegend, Inc.
  • Capralogics, Inc.
  • GenScript
  • Merck KGaA
  • ProteoGenix

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 Data Triangulation
2.2 Market Estimation Methodology
2.2.1 Insights from Primary Experts
2.3 Market Growth Rate Projections
2.4 Research Assumptions
2.5 Risk Analysis

3 Executive Summary

4 Premium Insights
4.1 Custom Antibody Market Overview
4.2 North America: Custom Antibody Market Share, by Type & Country (2020)
4.3 Custom Antibody Market Share, by Source (2020)
4.4 Custom Antibody Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Research Activities and Funding
5.2.1.2 Quality Concerns Over Catalog Antibodies
5.2.1.3 Growing Industry-Academia Collaborations
5.2.1.4 Increasing Focus on Therapeutic Antibodies and Extensive Pipeline Drugs
5.2.2 Market Restraints
5.2.2.1 Cost- and Time-Intensive Antibody Development Process
5.2.3 Market Opportunities
5.2.3.1 High Growth Opportunities in Developing Countries
5.2.3.2 Increasing Demand for Personalized Medicine in Protein Therapeutics
5.2.3.3 Increasing Focus on Biomarker Discovery
5.2.4 Market Challenges
5.2.4.1 Presence of Alternative Antibodies
5.3 Porter's Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Degree of Competition
5.4 Technological Analysis
5.4.1 Custom Antibody Services
5.5 Patent Analysis
5.6 Pricing Analysis
5.7 Regulatory Landscape
5.8 Impact of COVID-19 on the Custom Antibody Market
5.9 Value Chain Analysis of the Custom Antibody Market
5.10 Key Industry Trends
5.10.1 Increasing Focus on Antibody Drug Conjugate
5.10.2 Increasing Focus on Biospecific Antibodies

6 Custom Antibody Market, by Service
6.1 Introduction
6.2 Antibody Development
6.2.1 Antibody Characterization
6.2.1.1 Characterization Eliminates Antibodies with Heterogeneities That May Hamper Research Studies
6.2.2 Antigen Preparation
6.2.3 Immunization & Hybridoma Production
6.3 Antibody Production & Purification
6.3.1 Rising Demand for High-Quality Antibodies to Drive Market Growth
6.4 Antibody Fragmentation & Labeling
6.4.1 Increased Research Activities Coupled with the Need for Specific Antibody Detection to Drive Market Growth

7 Custom Antibody Market, by Type
7.1 Introduction
7.2 Monoclonal Antibodies
7.2.1 Monoclonal Antibodies Segment to Dominate the Market During the Forecast Period
7.3 Polyclonal Antibodies
7.3.1 Polyclonal Antibodies Are Preferred in Proteomics Research for the Detection of Denatured Proteins
7.4 Recombinant Antibodies
7.4.1 Research Reproducibility Offered by These Antibodies is Driving Their Demand
7.5 Other Custom Antibodies

8 Custom Antibody Market, by Source
8.1 Introduction
8.2 Mice
8.2.1 Mice Are the Most Preferred Hosts for Monoclonal Antibody Production
8.3 Rabbits
8.3.1 Antibodies Developed in Rabbits Eliminate the Limitation of Self-Antigen Recognition in Humans
8.4 Other Sources

9 Custom Antibody Market, by Research Area
9.1 Introduction
9.2 Oncology
9.2.1 Use of Antibodies Has Increased Considerably in Cancer Research
9.3 Infectious Diseases
9.3.1 Antibodies Are Widely Used in R&D for the Development of Vaccines & Therapeutics Against Various Infectious Diseases
9.4 Immunology
9.4.1 Assessment of Cell Surface Antigens Using Antibodies Forms An Important Field of Research in Immunology
9.5 Neurobiology
9.5.1 Neurobiology is One of the Fastest-Growing Segments in Terms of Research Being Undertaken Utilizing Antibodies
9.6 Stem Cells
9.6.1 Availability of High-Quality Antibodies Has Boosted Stem Cell Research
9.7 Cardiovascular Disease
9.7.1 Identification & Characterization of CVD Biomarkers is An Important Research Area Utilizing Antibodies
9.8 Other Research Areas

10 Custom Antibody Market, by End-User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Pharmaceutical & Biotechnology Companies Are the Largest End-Users of Custom Antibodies
10.3 Academic & Research Institutes
10.3.1 Increase in DNA Sequencing Studies and Proteomic Research to Drive Market Growth
10.4 Contract Research Organizations
10.4.1 Contract Research Organizations Provide Affordable Outlets for Companies and Academia to Pursue New Medicines

11 Custom Antibody Market, by Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Growing Research in the Field of Structure-Based Drug Design and Therapeutic mAbs to Drive Market Growth
11.2.2 Canada
11.2.2.1 Increasing Genomic Research to Drive the Adoption of Custom Antibodies in the Coming Years
11.3 Europe
11.3.1 Germany
11.3.1.1 High Investments for the Development of ADCs Support the Growth of the Custom Antibody Market in Germany
11.3.2 UK
11.3.2.1 Growing Research Investments to Drive Growth in the Life Science Research Market
11.3.3 France
11.3.3.1 Expanding Pipeline of Therapeutic mAbs Along with Increasing Investments in Research Are Supporting Market Growth
11.3.4 Italy
11.3.4.1 Growing Proteomics and Genomics Research at the Academic Level to Play a Key Role in Market Growth in Italy
11.3.5 Spain
11.3.5.1 Increasing Focus on the Advancement of Translational Personalized Medicine is Expected to Drive Market Growth
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.1.1 Large Number of Research Initiatives Toward the Development of Various ADCs Are Supporting Market Growth in Japan
11.4.2 China
11.4.2.1 China is One of the Fastest-Growing Markets in the Research Sector and is Expected to Dominate the Market in the Coming Years
11.4.3 India
11.4.3.1 Research for Generic mAbs and Fusion mAbs as Therapeutics is Expected to Propel the Custom Antibody Market in the Country
11.4.4 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Increasing Applications of Research-Specific Custom Antibodies to Drive Market Growth in Latin America
11.6 Middle East & Africa
11.6.1 Growing Focus of Pharmaceutical Companies on Africa to Drive the Market for Custom Antibodies in the Region

12 Competitive Landscape
12.1 Introduction
12.2 Right-To-Win Approaches Adopted by Key Market Players
12.3 Market Share Analysis
12.4 Growth Strategies Adopted by Major and Emerging Players
12.4.1 Custom Antibody Market: Key Deals (January 2018 to April 2021)
12.4.2 Custom Antibody Market: Key Expansions (January 2018 to April 2021)
12.5 Custom Antibody Market: Company Evaluation Matrix, 2020
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants

13 Company Profiles
13.1 Key Market Players
13.1.1 Thermo Fisher Scientific, Inc.
13.1.1.1 Business Overview
13.1.1.2 Services Offered
13.1.1.3 SWOT Analysis
13.1.1.4 Recent Developments
13.1.1.5 Analyst's View
13.1.2 Genscript
13.1.2.1 Business Overview
13.1.2.2 Services Offered
13.1.2.3 SWOT Analysis
13.1.2.4 Recent Developments
13.1.2.5 Analyst's View
13.1.3 Abcam plc
13.1.3.1 Business Overview
13.1.3.2 Services Offered
13.1.3.3 SWOT Analysis
13.1.3.4 Recent Developments
13.1.3.5 Analyst's View
13.1.4 Cell Signaling Technology, Inc.
13.1.4.1 Business Overview
13.1.4.2 Services Offered
13.1.4.3 Recent Developments
13.1.5 Bio-Rad Laboratories, Inc.
13.1.5.1 Business Overview
13.1.5.2 Services Offered
13.1.5.3 SWOT Analysis
13.1.6 Merck KGaA
13.1.6.1 Business Overview
13.1.6.2 Services Offered
13.1.6.3 SWOT Analysis
13.1.6.4 Recent Developments
13.1.7 Agilent Technologies, Inc.
13.1.7.1 Business Overview
13.1.7.2 Services Offered
13.1.7.3 Recent Developments
13.1.8 BioLegend, Inc.
13.1.8.1 Business Overview
13.1.8.2 Services Offered
13.1.8.3 Recent Developments
13.1.9 Rockland Immunochemicals, Inc.
13.1.9.1 Business Overview
13.1.9.2 Services Offered
13.1.10 ProMab Biotechnologies, Inc.
13.1.10.1 Business Overview
13.1.10.2 Services Offered
13.1.11 Innovagen AB
13.1.11.1 Business Overview
13.1.11.2 Services Offered
13.1.12 ProteoGenix
13.1.12.1 Business Overview
13.1.12.2 Services Offered
13.1.13 Bio-Techne
13.1.13.1 Business Overview
13.1.13.2 Services Offered
13.1.14 Creative Diagnostics
13.1.14.1 Business Overview
13.1.14.2 Services Offered
13.1.15 Sino Biological, Inc.
13.1.15.1 Business Overview
13.1.15.2 Services Offered
13.1.16 RayBiotech, Inc.
13.1.16.1 Business Overview
13.1.16.2 Services Offered
13.1.17 Abbiotec, Inc.
13.1.17.1 Business Overview
13.1.17.2 Services Offered
13.1.18 Prosci
13.1.18.1 Business Overview
13.1.18.2 Services Offered
13.1.19 Boster Biological Technology
13.1.19.1 Business Overview
13.1.19.2 Services Offered
13.1.20 Capralogics, Inc.
13.1.20.1 Business Overview
13.1.20.2 Services Offered

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: the Subscription Portal
14.3 Available Customizations

List of Tables
Table 1 Custom Antibody Market: Impact Analysis of Drivers, Restraints, Opportunities, and Challenges
Table 2 Global Pharmaceutical R&D Expenditure, 2010-2025 (USD Billion)
Table 3 Custom Antibody Market: Porter's Five Forces Analysis
Table 4 Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 5 Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 6 Antibody Development Market, by Region, 2019-2026 (USD Million)
Table 7 Antibody Characterization Market, by Region, 2019-2026 (USD Million)
Table 8 Antigen Preparation Market, by Region, 2019-2026 (USD Million)
Table 9 Immunization & Hybridoma Production Market, by Region, 2019-2026 (USD Million)
Table 10 Antibody Production & Purification Market, by Region, 2019-2026 (USD Million)
Table 11 Antibody Fragmentation & Labeling Market, by Region, 2019-2026 (USD Million)
Table 12 Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 13 Custom Monoclonal Antibodies Market, by Region, 2019-2026 (USD Million)
Table 14 Custom Polyclonal Antibodies Market, by Region, 2019-2026 (USD Million)
Table 15 Custom Recombinant Antibodies Market, by Region, 2019-2026 (USD Million)
Table 16 Other Custom Antibodies Market, by Region, 2019-2026 (USD Million)
Table 17 Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 18 Custom Antibody Market for Mice, by Region, 2019-2026 (USD Million)
Table 19 Custom Antibody Market for Rabbits, by Region, 2019-2026 (USD Million)
Table 20 Custom Antibody Market for Other Sources, by Region, 2019-2026 (USD Million)
Table 21 Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 22 Custom Antibody Market for Oncology, by Region, 2019-2026 (USD Million)
Table 23 Custom Antibody Market for Infectious Diseases, by Region, 2019-2026 (USD Million)
Table 24 Custom Antibody Market for Immunology, by Region, 2019-2026 (USD Million)
Table 25 Custom Antibody Market for Neurobiology, by Region, 2019-2026 (USD Million)
Table 26 Custom Antibody Market for Stem Cells, by Region, 2019-2026 (USD Million)
Table 27 Custom Antibody Market for Cardiovascular Disease, by Region, 2019-2026 (USD Million)
Table 28 Custom Antibody Market for Other Research Areas, by Region, 2019-2026 (USD Million)
Table 29 Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 30 Custom Antibody Market for Pharmaceutical & Biotechnology Companies, by Region, 2019-2026 (USD Million)
Table 31 Custom Antibody Market for Academic & Research Institutes, by Region, 2019-2026 (USD Million)
Table 32 Custom Antibody Market for Contract Research Organizations, by Region, 2019-2026 (USD Million)
Table 33 Custom Antibody Market, by Region, 2019-2026 (USD Million)
Table 34 North America: Custom Antibody Market, by Country, 2019-2026 (USD Million)
Table 35 North America: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 36 North America: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 37 North America: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 38 North America: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 39 North America: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 40 North America: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 41 Us: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 42 Us: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 43 Us: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 44 Us: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 45 Us: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 46 Us: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 47 Canada: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 48 Canada: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 49 Canada: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 50 Canada: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 51 Canada: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 52 Canada: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 53 Europe: Custom Antibody Market, by Country, 2019-2026 (USD Million)
Table 54 Europe: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 55 Europe: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 56 Europe: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 57 Europe: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 58 Europe: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 59 Europe: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 60 Germany: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 61 Germany: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 62 Germany: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 63 Germany: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 64 Germany: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 65 Germany: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 66 UK: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 67 UK: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 68 UK: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 69 UK: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 70 UK: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 71 UK: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 72 France: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 73 France: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 74 France: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 75 France: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 76 France: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 77 France: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 78 Italy: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 79 Italy: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 80 Italy: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 81 Italy: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 82 Italy: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 83 Italy: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 84 Spain: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 85 Spain: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 86 Spain: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 87 Spain: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 88 Spain: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 89 Spain: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 90 RoE: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 91 RoE: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 92 RoE: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 93 RoE: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 94 RoE: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 95 RoE: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 96 Asia-Pacific: Custom Antibody Market, by Country, 2019-2026 (USD Million)
Table 97 Asia-Pacific: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 98 Asia-Pacific: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 99 Asia-Pacific: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 100 Asia-Pacific: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 101 Asia-Pacific: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 102 Asia-Pacific: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 103 Japan: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 104 Japan: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 105 Japan: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 106 Japan: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 107 Japan: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 108 Japan: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 109 China: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 110 China: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 111 China: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 112 China: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 113 China: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 114 China: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 115 India: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 116 India: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 117 India: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 118 India: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 119 India: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 120 India: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 121 RoAPAC: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 122 RoAPAC: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 123 RoAPAC: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 124 RoAPAC: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 125 RoAPAC: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 126 RoAPAC: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 127 Latin America: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 128 Latin America: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 129 Latin America: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 130 Latin America: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 131 Latin America: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 132 Latin America: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 133 Middle East & Africa: Custom Antibody Market, by Service, 2019-2026 (USD Million)
Table 134 Middle East & Africa: Antibody Development Market, by Type, 2019-2026 (USD Million)
Table 135 Middle East & Africa: Custom Antibody Market, by Type, 2019-2026 (USD Million)
Table 136 Middle East & Africa: Custom Antibody Market, by Source, 2019-2026 (USD Million)
Table 137 Middle East & Africa: Custom Antibody Market, by Research Area, 2019-2026 (USD Million)
Table 138 Middle East & Africa: Custom Antibody Market, by End-User, 2019-2026 (USD Million)
Table 139 Thermo Fisher Scientific, Inc.: Business Overview
Table 140 Deals, January 2018-March 2021
Table 141 GenScript: Business Overview
Table 142 Deals, January 2018-March 2021
Table 143 Abcam plc: Business Overview
Table 144 Deals, January 2018-March 2021
Table 145 Cell Signaling Technology, Inc.: Business Overview
Table 146 Expansions, January 2018-March 2021
Table 147 Bio-Rad Laboratories, Inc.: Business Overview
Table 148 Merck KGaA.: Business Overview
Table 149 Deals, January 2018-March 2021
Table 150 Expansions, January 2018-March 2021
Table 151 Agilent Technologies, Inc.: Business Overview
Table 152 Expansions, January 2018-March 2021
Table 153 BioLegend, Inc.: Business Overview
Table 154 Deals, January 2018-March 2021
Table 155 Rockland Immunochemicals, Inc.: Business Overview
Table 156 ProMab Biotechnologies, Inc: Business Overview
Table 157 Innovagen AB: Business Overview
Table 158 ProteoGenix: Business Overview
Table 159 Bio-Techne: Business Overview
Table 160 Creative Diagnostics: Business Overview
Table 161 Sino Biological, Inc.: Business Overview
Table 162 RayBiotech, Inc.: Business Overview
Table 163 Abbiotec, Inc.: Business Overview
Table 164 Prosci: Business Overview
Table 165 Boster Biological Technology: Business Overview
Table 166 Capralogics, Inc.: Business Overview

List of Figures
Figure 1 Breakdown of Primaries: Custom Antibody Market
Figure 2 Data Triangulation Methodology
Figure 3 Market Size Estimation: Approach 1 (Revenue-Based Estimation)
Figure 4 Custom Antibody Market Size Estimation (Supply-Side Analysis), 2020
Figure 5 Market Size Validation from Primary Sources
Figure 6 Custom Antibody Market (Supply Side): CAGR Projections
Figure 7 Custom Antibody Market Share, by Service, 2020 Vs. 2026
Figure 8 Custom Antibody Market Share, by Type, 2020
Figure 9 Custom Antibody Market Share, by Source, 2021 Vs. 2026
Figure 10 Custom Antibody Market Share, by Research Area, 2020
Figure 11 Custom Antibody Market Share, by End-User, 2020
Figure 12 Geographical Snapshot of the Custom Antibody Market
Figure 13 Quality Concerns Over Catalog Antibodies to Drive Market Growth
Figure 14 Monoclonal Antibodies Accounted for the Largest Share of the North American Custom Antibody Market in 2020
Figure 15 Mice Are the Largest Source of Custom Antibodies
Figure 16 Asia-Pacific to Register the Highest Growth in the Custom Antibody Market from 2021 to 2026
Figure 17 Number of Patents Granted for Custom Antibodies, January 2010-December 2020
Figure 18 Custom Antibody Market: Geographic Snapshot (2021)
Figure 19 North America: Custom Antibody Market Snapshot
Figure 20 Asia-Pacific: Custom Antibody Market Snapshot
Figure 21 Custom Antibody Market: Market Share Analysis of Key Players (2020)
Figure 22 Custom Antibody Market: Company Evaluation Matrix, 2020
Figure 23 Thermo Fisher Scientific, Inc.: Company Snapshot (2019)
Figure 24 Genscript: Company Snapshot (2019)
Figure 25 Abcam plc: Company Snapshot (2020)
Figure 26 Bio-Rad Laboratories, Inc.: Company Snapshot (2020)
Figure 27 Merck KGaA.: Company Snapshot (2020)
Figure 28 Agilent Technologies, Inc.: Company Snapshot (2020)
Figure 29 Bio-Techne: Company Snapshot (2020)


Note: Product cover images may vary from those shown
  • Abbiotec, Inc.
  • Abcam plc
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • BioLegend, Inc.
  • Boster Biological Technology
  • Capralogics, Inc.
  • Cell Signaling Technology, Inc.
  • Creative Diagnostics
  • GenScript
  • Innovagen AB
  • Merck KGaA
  • ProMab Biotechnologies, Inc.
  • Prosci
  • ProteoGenix
  • RayBiotech, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...